These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2139399)

  • 1. Development of nephropathy in diabetic patients with a single kidney.
    Sampson MJ; Drury PL
    Diabet Med; 1990; 7(3):258-60. PubMed ID: 2139399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired oligonephropathy and diabetic nephropathy.
    Nielsen FS; Gall MA; Parving HH
    Am J Kidney Dis; 1995 Dec; 26(6):898-903. PubMed ID: 7503063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glomerular hyperfiltration and diabetic nephropathy].
    Prkacin I; Bulum T
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():37-41. PubMed ID: 23513414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
    Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
    Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre.
    Wolf G; Busch M; Müller N; Müller UA
    Nephrol Dial Transplant; 2011 Dec; 26(12):4017-23. PubMed ID: 21493815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes.
    Franzén S; Friederich-Persson M; Fasching A; Hansell P; Nangaku M; Palm F
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1171-8. PubMed ID: 24623147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy.
    Brenner BM; Hostetter TH; Olson JL; Rennke HG; Venkatachalam MA
    Acta Endocrinol Suppl (Copenh); 1981; 242():7-10. PubMed ID: 6940408
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of unilateral nephrectomy on three patients with histopathological evidence of diabetic glomerulosclerosis in the resected kidney.
    Fattor RA; Silva FG; Eigenbrodt EH; D'Agati V; Seney F
    J Diabet Complications; 1987; 1(3):107-13. PubMed ID: 2969907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial relaxation factor in the development of diabetic nephropathy].
    Shestakova MV; Severina IS; Dedov II; Ragozin AK; Belushkina NN; Riaposova IK
    Vestn Ross Akad Med Nauk; 1995; (5):30-4. PubMed ID: 7626982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.
    Komers R; Oyama TT; Beard DR; Tikellis C; Xu B; Lotspeich DF; Anderson S
    Kidney Int; 2011 Feb; 79(4):432-42. PubMed ID: 20962741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect.
    Wilczek HE; Jaremko G; Tydén G; Groth CG
    Transplantation; 1995 Jan; 59(1):51-7. PubMed ID: 7839428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.
    Bardoux P; Martin H; Ahloulay M; Schmitt F; Bouby N; Trinh-Trang-Tan MM; Bankir L
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10397-402. PubMed ID: 10468619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy after renal transplantation. Clinical and pathologic features.
    Hariharan S; Smith RD; Viero R; First MR
    Transplantation; 1996 Sep; 62(5):632-5. PubMed ID: 8830828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic Nephropathy Following Posttransplant Diabetes Mellitus.
    Nagib AM; Elsayed Matter Y; Gheith OA; Refaie AF; Othman NF; Al-Otaibi T
    Exp Clin Transplant; 2019 Apr; 17(2):138-146. PubMed ID: 30945628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?
    Mogensen CE
    Diabetes; 1990 Jul; 39(7):761-7. PubMed ID: 2191882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man.
    Bohman SO; Tydén G; Wilczek H; Lundgren G; Jaremko G; Gunnarsson R; Ostman J; Groth CG
    Diabetes; 1985 Mar; 34(3):306-8. PubMed ID: 3918902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.
    O'Donnell MP; Kasiske BL; Keane WF
    FASEB J; 1988 May; 2(8):2339-47. PubMed ID: 3282959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.